Abstract
No AccessJournal of UrologyAdult Urology1 Feb 2013Preclinical and Clinical Activity of Sunitinib in Patients with Cisplatin-Refractory or Multiply Relapsed Germ Cell Tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group Cooperative Study Jerome P. RichieM.D. Jerome P. RichieJerome P. Richie More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.10.091AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Preclinical and Clinical Activity of Sunitinib in Patients with Cisplatin-Refractory or Multiply Relapsed Germ Cell Tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group Cooperative Study." The Journal of Urology, 189(2), pp. 533–534 © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 2February 2013Page: 533-534 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jerome P. Richie More articles by this author Expand All Advertisement PDF downloadLoading ...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
